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SHORT REPORT
Cigarette smoking and risk of glioma: A prospective cohort study
Stephanie A. Navarro Silvera1*, Anthony B. Miller2 and Thomas E. Rohan1
1
Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA
2
Department of Public Health Sciences, University of Toronto, Toronto, Canada
The etiology of glioma, the most commonly diagnosed malignant
brain tumor among adults in the United States, is poorly understood. N-nitroso compounds are known carcinogens, which are
found in cigarette smoke and can induce gliomas in rats. On this
basis, it has been hypothesized that cigarette smoking may be
associated with an increased risk of glioma. We investigated the
association between cigarette smoking and glioma risk in the
National Breast Screening Study, which included 89,835 Canadian
women aged 40–59 years at recruitment between 1980 and 1985.
Linkages to national cancer and mortality databases yielded data
on cancer incidence and deaths from all causes, respectively, with
follow-up ending between 1998 and 2000. Cox proportional hazard models were used to estimate hazard ratios (HRs) and 95%
conﬁdence intervals (CIs) for the association between cigarette
smoking and risk of glioma. During a mean of 16.4 years of follow-up, we observed 120 incident glioma cases. Among ever smokers, women who reported having quit smoking had a 51% increase
in risk of glioma compared with never smokers (HR 5 1.51, 95%
CI 5 0.97–2.34), while current smokers did not appear to have an
increase in risk. When the association with former smokers was
further examined by years since quitting, women who had quit
smoking >10 years before baseline were at a decreased risk of
glioma compared with women who had quit within the 10 years
prior to baseline (HR 5 0.55, 95% CI 5 0.29–1.07), indicating that
the association between former smokers and glioma may be driven
by women, who recently quit smoking. Compared with nonsmokers, duration of cigarette smoking, number of cigarettes
smoked per day and pack-years of smoking were associated with
increased glioma risk, although the increases in risk were relatively modest. The present study provides some support for a positive association between cigarette smoking and risk of glioma.
' 2005 Wiley-Liss, Inc.
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Gliomas, which arise from neuroepithelial cells, are one of the
2 main histopathological types of brain tumor.1 The etiology of
glioma, the most commonly diagnosed malignant brain tumor
among adults in the United States,1,2 is not well understood.
Indeed, there are few well-established risk factors for glioma
beyond ionizing radiation,1,3 male gender,1 and possibly reproductive and menstrual factors.4 In addition, it has been hypothesized
that cigarette smoking may be involved in the etiology of glioma,5
based on evidence that N-nitroso compounds, such as those found
in cigarette smoke, have been shown to induce glioma in rats
when administered intravenously.6,7
The epidemiologic literature regarding cigarette smoking and
brain cancer risk is based primarily on case-control studies, all of
which have found no association with ever smoking.8–21 A recent
cohort study by Eﬁrd et al.,22 however, observed an increased risk
of glioma in those who reported smoking greater than 2 packs of
cigarettes per day. Given the limited data from prospective studies, we examined the association between smoking history and
glioma risk in a cohort of Canadian women.
Material and methods
Study population
The design of our study has been described in detail elsewhere.23 Brieﬂy, 89,835 women, aged 40–59 years, were recruited
into the Canadian National Breast Screening Study between 1980
and 1985 from the general Canadian population by various means,
Publication of the International Union Against Cancer

including personal invitation by letter, group mailings to employees of large institutions and to members of professional associations, advertisements in newspapers and public service announcements on radio and television.24
Questionnaires
At recruitment into the cohort, participants completed selfadministered questionnaires that sought information on demographic characteristics and lifestyle factors. Information on smoking history was obtained from participants by asking them whether
or not they had ever smoked; those who reported ever smoking
were then asked to provide information on how many cigarettes
they smoked per day, how many years they had smoked, and for
former smokers, the year that they had ceased smoking.
Ascertainment of incident glioma cases and deaths
from all causes
Incident cases of glioma (ICD-M codes 9380/3-9473/3 and
9490/0-9506/0) and deaths from all causes were ascertained
respectively by means of computerized record linkages to the
Canadian Cancer Database and to the National Mortality Database, both of which are maintained by Statistics Canada. The linkages to the databases yielded data on cancer incidence and allcause mortality to December 31, 2000 for women in Ontario,
December 31, 1998 for women in Quebec and December 31, 1999
for women in other provinces.
Statistical analysis
Of the 89,835 women recruited into the study, we excluded
women with prevalent glioma at baseline (n 5 5) and women for
whom complete information on smoking history was not available
(n 5 121), leaving 89,709 women available for analysis, amongst
whom 117 incident cases of glioma were observed. Participants
with other prevalent cancers (n 5 211) at baseline were not
excluded from the analyses, because the results of analyses with
and without such subjects were essentially the same.
For the analyses, study participants were considered to be at risk
from their date of enrolment until the date of diagnosis of glioma
(the outcome of interest), the termination of follow-up (the date to
which cancer incidence data were available for women in the corresponding province) or death, whichever occurred earliest. Cox
proportional hazards models (using age as the time scale) were
used to estimate hazard ratios (HR) and 95% conﬁdence intervals
(CI) for the association between smoking history variables and
glioma risk. Using the information on smoking history reported by
the participants, we calculated age at the commencement of smoking for current smokers, by subtracting the number of years they
reported smoking from their age at baseline, and for former smokers, by subtracting the number of years they reported smoking
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CIGARETTE SMOKING AND RISK OF GLIOMA
TABLE I – BASELINE CHARACTERISTICS OF THE STUDY POPULATION BY OUTCOME

Mean age (years)
Mean education (years)
Mean body mass index (kg/m2)
Parity (% parous)
Mean age at ﬁrst live birth (years)
Mean age at menarche (years)
Menopausal status (% postmenopausal)
Smoking history (% ever)
Mean age started smoking2
Mean number of years smoked
Mean number of cigarettes smoked per day
Mean number of pack–years

Cases of incident
glioma (n 5 117)

Noncases
(n 5 88,592)

50.4 (5.5)1
12.1 (2.9)
25.4 (4.3)
87.5
24.6 (5.0)
13.3 (3.0)
56.2
49.7
23.1 (8.6)
21.5 (11.3)
18.2 (12.7)
22.4 (21.1)

48.5 (5.6)
12.6 (3.1)
25.1 (4.7)
85.6
24.2 (4.7)
12.8 (2.2)
43.2
48.9
22.7 (7.5)
19.0 (10.4)
16.7 (11.2)
18.3 (16.6)

1
Values in parentheses indicate SDs.–2Results for smoking duration, intensity, pack–years and age
started smoking are among ever smokers only.

from the age at which they stopped smoking. Cut points for smoking variables were determined a priori based on their distribution
among smokers. All models included terms for study center and
randomization group (intervention or control). In keeping with the
literature,10,20,22 multivariate analyses included additional adjustment for level of education (<high school, >high school) and
body mass index (BMI). Multivariate models also included adjustment for reproductive factors (parity, age at ﬁrst live birth, age at
menarche and menopausal status), based on the evidence that
these variables may be associated with glioma risk.4,25,26 The cut
points for all covariates were determined a priori. The cut points
for BMI correspond to the National Institutes of Health guidelines,
which classify BMI as normal weight (<25 kg/m2), overweight
(25–<30 kg/m2) or obese (>30 kg/m2). The cut points for all other
covariates were based on the distribution of each of the variables
at baseline. To test for trends in risk with increasing levels of the
exposures of interest, we assigned the category median, and then,
ﬁtted the assigned value of each risk factor as a continuous variable in the risk models. We then evaluated the statistical signiﬁcance of the corresponding coefﬁcient, using the Wald test.27 Use
of the lifetest procedure in SASTM showed that the proportional
hazards assumption was met in the ﬁtted models. All analyses
were performed using SAS version 9 (SAS Institute Cary, NC).
Results
The average duration of follow-up for cohort members was 16.5
years (1,462,004 person-years), and the mean (SD) age at diagnosis of the cases was 60.0 (7.1) years. Table I shows the distribution
of demographic characteristics of the study population (collected
at baseline), with case status at the end of follow-up. Cases tended
to be slightly older at baseline than did noncases. Also, compared
with noncases, cases were more likely to be parous, tended to have
an older age at menarche, were more likely to be postmenopausal
at baseline and reported slightly fewer years of cigarette smoking.
Table II shows that in adjusted models ever smoking was associated with a statistically nonsigniﬁcant 30% increase in risk of
glioma. In addition, former smokers were at increased risk of
glioma compared with never smokers (HR 5 1.51, 95% CI 5
0.97–2.34), while current smokers did not appear to be at
increased risk (HR 5 1.05, 95% CI 5 0.62–1.78). Upon categorizing former smokers by years since having quit smoking, we found
an inverse association between former smokers who quit >10
years prior to baseline compared with those who quit within the
10 years prior to baseline (HR 5 0.39, 95% CI 5 0.19–0.82) (data
not shown). Compared with never smokers, there was some suggestion of an increase in risk with increasing number of years
smoked (ptrend 5 0.06). Risk also increased with number of cigarettes smoked per day (ptrend 5 0.08) and pack-years of smoking
(ptrend 5 0.07). In addition, compared with never smokers, there
was a 67% increase in risk among smokers who started smoking
before the age of 20. When the tests for linear trend excluded the

TABLE II – MULTIVARIATE–ADJUSTED HAZARD RATIOS AND 95%
CIs FOR THE ASSOCIATION BETWEEN CIGARETTE SMOKING
AND RISK OF INCIDENT GLIOMA
Factor

Cases/person years

Never smoked
59/751,385
Ever smoked
58/710,619
Former smoker
38/392,746
Current smoker
20/317,874
Age started smoking (years)
<20
19/236,482
20–21
18/228,978
>21
21/245,159
ptrend
Number of years smoked
<10
17/228,081
11–20
16/233,722
>20
25/248,816
ptrend
Number of cigarettes/day
<10
14/171,808
11–19
24/191,917
>19
20/346,894
ptrend
Pack–years
<5
14/243,762
6–15
24/236,113
>15
20/230,744
ptrend

Multivariate1

1.00 (Reference)
1.30 (0.88–1.93)2
1.51 (0.97–2.34)
1.05 (0.62–1.78)
1.67 (1.03–2.72)
0.85 (0.48–1.53)
1.37 (0.71–2.65)
0.63
0.55 (0.20–1.53)
1.19 (0.63–2.26)
1.51 (0.97–2.34)
0.06
0.68 (0.31–1.50)
1.49 (0.86–2.61)
1.44 (0.90–2.31)
0.08
0.85 (0.46–1.58)
1.51 (0.83–2.75)
1.50 (0.92–2.44)
0.07

1
Multivariate adjusted for age (time to event variable), education
(<high school, >high school), body mass index (<25, 25–29, >30),
parity (parous vs. nulliparous), age at ﬁrst live birth (nulliparous, <20,
20–24, >24), age at menarche (<12, 13–14, >14), menopausal status,
study center and allocation group.–2Values in parentheses indicate
95% CIs.

reference category (never smokers), the trends were similar for
number of years smoked (ptrend 5 0.06), number of cigarettes
smoked per day (ptrend 5 0.10), pack-years of smoking (ptrend 5
0.14) and age started smoking (ptrend 5 0.24) (data not shown).
We also examined the associations after mutual adjustment for
the smoking variables. For example, given that women who
started smoking before age 20 had greater risk than those who
started smoking at later ages, we examined the association
between smoking duration and glioma risk after controlling for
when women started smoking, since women who started smoking
at younger ages were more likely to have smoked longer. Mutual
adjustment did not signiﬁcantly alter the association between
smoking duration or age of smoking commencement and risk of
glioma among smokers (data not shown). Mutual adjustment for
both smoking duration (number of years smoked) and smoking
intensity (cigarettes per day) among smokers attenuated the asso-
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ciation between each of these variables and glioma risks somewhat (data not shown).
We were unable to fully examine the association between
smoking history and glioma risk by histology (e.g., glioblastoma,
other astrocytoma and other glioma) given the small number of
cases of other astrocytoma (n 5 34) and other glioma (n 5 12).
For glioblastoma (n 5 71), there were statistically signiﬁcant positive associations with number of years smoked (HR for >20 years
vs. never smokers 5 2.66, 95% CI 5 1.10–6.40, ptrend 5 0.02),
number of cigarettes smoked per day (HR for >19 cigarettes/day
vs. never smokers 5 2.86, 95% CI 5 1.14–7.16, ptrend 5 0.07)
and pack-years of smoking (HR for >15 pack-years vs. never
smokers 5 2.52, 95% CI 5 1.03–6.20, ptrend 5 0.04) (data not
shown).
Discussion
In the prospective study reported here, we found that ever having
smoked cigarettes was associated with a modest increase in risk of
glioma. In addition, women who reported being former smokers
were at increased risk of glioma compared with never smokers,
while current smokers did not appear to be at an increased risk.
However, after categorizing former smokers by years since having
quit smoking, we found an inverse association between former
smokers who quit >10 years prior to baseline compared with those
who quit within the 10 years prior to baseline, indicating that the
association between former smokers and glioma may have been
driven by women who recently quit smoking. Other aspects of cigarette smoking, including greater smoking intensity and duration,
were also associated with modest increases in glioma risk.
The mechanism by which cigarette consumption might increase
risk of glioma is unknown. Experimentally, intravenous administration of N-nitroso compounds has been shown to induce glioma
formation in rats.6 While there is evidence that these compounds
can enter the brain during gestation (due to maternal cigarette
smoking),28 it is not known whether N-nitroso compounds from
cigarette smoke cross the blood-brain barrier in adults. However,
there is evidence that nicotine increases the permeability of the
blood-brain barrier in vivo,29 which may allow carcinogens, such
as nitrosamines, to reach brain tissue.

Our ﬁndings differ from those of most studies to date, which
have largely found no association between cigarette smoking and
risk of glioma.8–21 However, these were case-control studies,
which are susceptible to selection and recall bias. In the only other
prospective study to date, Eﬁrd et al.22 analyzed data from a prospective cohort in California (130 incident cases) and, similar to
our ﬁndings, they observed a 40% increase in risk for ever versus
never smokers (95% CI 5 1.0–2.1) and a 2-fold increase in risk of
glioma among study participants who reported smoking greater
than 2 packs per day compared with never smokers; the association between smoking and risk did not differ by type of cigarette
(e.g., ﬁltered versus unﬁltered, etc.), an aspect of smoking history
that we were not able to examine.
The main strength of this investigation is its prospective study
design, which eliminates the possibility of recall bias. As well, the
essentially complete follow-up of the cohort,30,31 based on linkage
to national cancer incidence and mortality databases, reduces the
likelihood that our results reﬂect bias due to differential followup. Although the number of incident cases of glioma in our study
population was relatively small, it is similar to that in the study of
Eﬁrd et al.,22 the only previous prospective study to date. Our
study is also limited, in which information on smoking was collected only at baseline, so that we were not able to take into
account changes in cigarette use over time. Given that smoking
rates are inversely associated with age,32 it is quite likely that
smoking habits would have changed over the course of follow-up,
possibly leading to misclassiﬁcation of exposure. However, such
misclassiﬁcation is quite likely to have been nondifferential,
resulting in some attenuation of the associations.
In conclusion, the results of our study provide support for a positive association between cigarette smoking and risk of glioma.
However, given that this is only the second prospective study to
date, additional studies are needed.
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